Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects

Acute myeloid leukemia (AML) is a malignant disease of immature myeloid cells and the most prevalent acute leukemia among adults. The oncogenic homo-tetrameric fusion protein RUNX1/ETO results from the chromosomal translocation t(8;21) and is found in AML patients. The nervy homology region 2 (NHR2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopalswamy, Mohanraj, Kroeger, Tobias, Bickel, David, Frieg, Benedikt, Akter, Shahina, Schott-Verdugo, Stephan, Viegas, Aldino, Pauly, Thomas, Mayer, Manuela, Przibilla, Julia, Reiners, Jens, Nagel-Steger, Luitgard, Smits, Sander H. J., Groth, Georg, Etzkorn, Manuel, Gohlke, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391460/
https://www.ncbi.nlm.nih.gov/pubmed/35986043
http://dx.doi.org/10.1038/s41598-022-17913-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391460/
https://www.ncbi.nlm.nih.gov/pubmed/35986043
http://dx.doi.org/10.1038/s41598-022-17913-6

Ejemplares similares